TSXV - Delayed Quote CAD

NuGen Medical Devices Inc. (NGMD.V)

0.0700
0.0000
(0.00%)
At close: May 16 at 3:58:44 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,009.8790
1,009.8790
331.4030
152.3580
137.6480
Cost of Revenue
487.9420
487.9420
166.5620
53.1900
45.4240
Gross Profit
521.9370
521.9370
164.8410
99.1680
92.2240
Operating Expense
5,679.4010
5,679.4010
8,205.6470
4,886.6580
7,736.9760
Operating Income
-5,157.4640
-5,157.4640
-8,040.8060
-4,787.4900
-7,644.7520
Net Non Operating Interest Income Expense
-1,848.7880
-1,848.7880
-1,236.3030
-860.5850
-1,217.3080
Other Income Expense
1,787.2080
1,787.2080
-51.3120
73.3280
1,757.9340
Pretax Income
-5,219.0440
-5,219.0440
-9,328.4210
-5,574.7470
-7,104.1260
Tax Provision
6.7390
6.7390
33.7960
3.1790
2.9560
Net Income Common Stockholders
-5,225.7830
-5,225.7830
-9,362.2170
-5,577.9260
-7,107.0820
Diluted NI Available to Com Stockholders
-5,225.7830
-5,225.7830
-9,362.2170
-5,577.9260
-7,107.0820
Basic EPS
-0.02
-0.02
-0.05
-0.06
-0.10
Diluted EPS
-0.02
-0.02
-0.05
-0.06
-0.10
Basic Average Shares
214,420.4910
214,420.4910
167,664.9930
90,102.0670
68,674.5020
Diluted Average Shares
214,420.4910
214,420.4910
167,664.9930
90,102.0670
68,674.5020
Total Operating Income as Reported
-5,157.4640
-5,157.4640
-8,048.0540
-4,794.0350
-7,671.2970
Rent Expense Supplemental
182.6890
182.6890
111.7150
92.0140
208.3690
Total Expenses
6,167.3430
6,167.3430
8,372.2090
4,939.8480
7,782.4000
Net Income from Continuing & Discontinued Operation
-5,225.7830
-5,225.7830
-9,362.2170
-5,577.9260
-7,107.0820
Normalized Income
-6,708.2893
-6,708.2893
-9,323.5014
-5,589.9744
-8,399.1635
Interest Income
--
--
--
--
20
Interest Expense
1,668.6290
1,668.6290
1,236.3030
1,011.4920
1,223.4950
Net Interest Income
-1,848.7880
-1,848.7880
-1,236.3030
-860.5850
-1,217.3080
EBIT
-3,550.4150
-3,550.4150
-8,092.1180
-4,563.2550
-5,880.6310
EBITDA
-2,904.6850
-2,904.6850
-7,401.2780
-3,910.8560
-5,090.0780
Reconciled Cost of Revenue
487.9420
487.9420
166.5620
53.1900
45.4240
Reconciled Depreciation
645.7300
645.7300
690.8400
652.3990
790.5530
Net Income from Continuing Operation Net Minority Interest
-5,225.7830
-5,225.7830
-9,362.2170
-5,577.9260
-7,107.0820
Total Unusual Items Excluding Goodwill
1,744.1250
1,744.1250
-64.5260
16.3280
1,757.9340
Total Unusual Items
1,744.1250
1,744.1250
-64.5260
16.3280
1,757.9340
Normalized EBITDA
-4,648.8100
-4,648.8100
-7,336.7520
-3,927.1840
-6,848.0120
Tax Rate for Calcs
0.0002
0.0002
0.0004
0.0003
0.0003
Tax Effect of Unusual Items
261.6188
261.6188
-25.8104
4.2796
465.8525
12/31/2021 - 11/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ASG.V Aurora Spine Corporation
0.3400
+6.25%
 
MDX.V MedX Health Corp
0.0750
+7.14%
 
IRMD IRADIMED CORPORATION
53.29
-1.39%
 
BLO.CN Cannabix Technologies Inc.
0.6000
-1.64%
 
VMD Viemed Healthcare, Inc.
6.80
+0.74%
 
STIM Neuronetics, Inc.
4.2900
0.00%
 
THRM.V Therma Bright Inc.
0.0200
+33.33%
 
RBOT Vicarious Surgical Inc.
7.35
-3.54%
 
CVRX CVRx, Inc.
6.99
+2.04%
 
TMDX TransMedics Group, Inc.
124.71
+2.14%